Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.
Conway C, Mitra A, Jewell R, Randerson-Moor J, Lobo S, Nsengimana J, Edward S, Sanders DS, Cook M, Powell B, Boon A, Elliott F, de Kort F, Knowles MA, Bishop DT, Newton-Bishop J. Conway C, et al. Among authors: bishop dt. Clin Cancer Res. 2009 Nov 15;15(22):6939-46. doi: 10.1158/1078-0432.CCR-09-1631. Epub 2009 Nov 3. Clin Cancer Res. 2009. PMID: 19887478 Free PMC article.
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.
Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Dos Santos Silva I, J Swerdlow A, Bishop DT, Newton Bishop JA. Bertram CG, et al. Among authors: bishop dt. J Invest Dermatol. 2002 Oct;119(4):961-5. doi: 10.1046/j.1523-1747.2002.01825.x. J Invest Dermatol. 2002. PMID: 12406345 Free article.
Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.
Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JG, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, Sobol H, Jacquemier J, Lyonet DS, Neuhausen SL, Weber B, Wagner T, Winqvist R, Bignon YJ, Monti F, Schmitt F, Lenoir G, Seitz S, Hamman U, Pharoah P, Lane G, Ponder B, Bishop DT, Easton DF. Lakhani SR, et al. Among authors: bishop dt. Clin Cancer Res. 2004 Apr 1;10(7):2473-81. doi: 10.1158/1078-0432.ccr-1029-3. Clin Cancer Res. 2004. PMID: 15073127
Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.
Harland M, Taylor CF, Bass S, Churchman M, Randerson-Moor JA, Holland EA, Mann GJ, Bishop DT, Newton Bishop JA. Harland M, et al. Among authors: bishop dt. Genes Chromosomes Cancer. 2005 Jun;43(2):128-36. doi: 10.1002/gcc.20177. Genes Chromosomes Cancer. 2005. PMID: 15761864
No Evidence for BRAF as a melanoma/nevus susceptibility gene.
Jackson S, Harland M, Turner F, Taylor C, Chambers PA, Randerson-Moor J, Swerdlow AJ, dos Santos Silva I, Beswick S, Bishop DT, Newton Bishop JA. Jackson S, et al. Among authors: bishop dt. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):913-8. doi: 10.1158/1055-9965.EPI-04-0568. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824163 Free article.
A mutation hotspot at the p14ARF splice site.
Harland M, Taylor CF, Chambers PA, Kukalizch K, Randerson-Moor JA, Gruis NA, de Snoo FA, ter Huurne JA, Goldstein AM, Tucker MA, Bishop DT, Bishop JA. Harland M, et al. Among authors: bishop dt, bishop ja. Oncogene. 2005 Jun 30;24(28):4604-8. doi: 10.1038/sj.onc.1208678. Oncogene. 2005. PMID: 15856016
The genetics of susceptibility to cutaneous melanoma.
Newton Bishop JA, Bishop DT. Newton Bishop JA, et al. Among authors: bishop dt. Drugs Today (Barc). 2005 Mar;41(3):193-203. doi: 10.1358/dot.2005.41.3.892524. Drugs Today (Barc). 2005. PMID: 15883616 Review.
Prevalence of 9p21 deletions in UK melanoma families.
Mistry SH, Taylor C, Randerson-Moor JA, Harland M, Turner F, Barrett JH, Whitaker L, Jenkins RB, Knowles MA, Bishop JA, Bishop DT. Mistry SH, et al. Among authors: bishop dt, bishop ja. Genes Chromosomes Cancer. 2005 Nov;44(3):292-300. doi: 10.1002/gcc.20238. Genes Chromosomes Cancer. 2005. PMID: 16032697
437 results